Article
Multi-omics profiling, in vitro and in vivo enhancer assays dissect the cis-regulatory…
medRxiv · 2022 · Stijn Van de Sompele
Key facts
| Title | Multi-omics profiling, in vitro and in vivo enhancer assays dissect the cis-regulatory mechanisms underlying North Carolina macular dystrophy, a retinal enhanceropathy |
|---|---|
| First author | Stijn Van de Sompele |
| Journal | medRxiv |
| Published | Jul 26, 2022 |
| DOI | 10.1101/2022.03.08.481329 |
| Devices mentioned | BK110039, DEN000008, K022086, K103302, K220060, K973350, K990827 |
| Product codes mentioned | JCI, JJH, JJQ, JQW, KIT, NDS, NGT, NJT, OOI, PFF, PFT, JLX and 2 more |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1